From Ola Spjuth:
Hi all Bioclipse developers,Bioclipse has outgrown its original design. We have therefore decidedto start the design of Bioclipse2, which will be a complete rewriteof the core API and extension points to overcome the manydeficiencies of the current design/implementation. I have establisheda wiki page for this (http://wiki.bioclipse.net/index.php?title=Bioclipse2). If you’d like to participate in the redesign,please add your name in the members section. The discussion will becarried out in IRC (irc.freenode.net, #bioclipse) and on this mailinglist.Cheers,/Ola
PMR: Bioclipse has received awards and its paper in BMC Bioinformatics is HIGHLY ACCESSED (this means many thousands of times).
[Topical interlude] This is, of course, an Open Access Journal. Here is all you need to know about OA (in BMC’s words)
Brief summary of what Open Access means for the reader:Articles with this logo are immediately and permanently available online. Unrestricted use, distribution and reproduction in any medium is permitted, provided the article is properly cited. See our open access charter.
Anyone is free:
- to copy, distribute, and display the work;
- to make derivative works;
- to make commercial use of the work;
Under the following conditions: Attribution
- the original author must be given credit;
- for any reuse or distribution, it must be made clear to others what the license terms of this work are;
- any of these conditions can be waived if the authors gives permission.
Statutory fair use and other rights are in no way affected by the above.
PMR: That’s it! No mumbo-jumbo about paying for multiple copies, Rightslink, copyright-retained-by-publisher etc. Simple conditions in English that can be understood and used. And yes, if anyone wishes to resell the article ther are permitted to AS LONG AS THE LICENCE AND COPYRIGHT ARE VISIBLE.
[Back to the code…] So, doubters of Open Source, please take note. It’s very good software and there are things below the surface that will make it even better. We absolutely need a smart client for science and Bioclipse is exactly what we want. Note, of course, that Bioclipse does chemistry.
The pharma industry needs Bioclipse. Please come out of hiding and offer to help. It will cost a fraction of what you already spend on commercial software.